1550 Participants Needed

Telehealth vs Clinic Management for High Blood Pressure

(TEAMS-BP Trial)

CB
KS
Overseen ByKelsey Shore
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Wake Forest University Health Sciences
Must be taking: Hypertension medications
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares two methods for managing high blood pressure in individuals who have had a stroke. One group will use Intensive Tailored Telehealth Management, receiving personalized plans and coaching through devices like smartphones. The other group will attend clinics for regular check-ups and receive advice via text messages through Intensive Clinic Management. Suitable participants have had a stroke, have uncontrolled high blood pressure, manage their care at home, and use a smartphone or tablet. As an unphased trial, this study provides a unique opportunity to explore innovative management strategies for this condition.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that treatments like Intensive Tailored Telehealth Management (ITTM) receive positive feedback from patients. Studies on telehealth models indicate that patients can safely monitor their blood pressure at home. Sending this information digitally allows doctors to manage treatment remotely, which patients find convenient and effective.

For Intensive Clinic Management (ICM), strong evidence supports that closely monitoring and controlling blood pressure is safe. Research has demonstrated that this approach can lower the risk of heart problems without significantly harming other organs, such as the kidneys.

Both treatments in this trial are based on proven methods, suggesting they are likely safe and well-tolerated. Participants in similar trials have generally experienced positive results with few issues.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for high blood pressure because they explore new ways to manage the condition beyond traditional in-person care. Intensive Tailored Telehealth Management (ITTM) offers a personalized approach by addressing individual barriers to care through remote monitoring and health coaching, which is more convenient for patients. On the other hand, Intensive Clinic Management (ICM) provides structured in-person follow-ups but incorporates digital health promotion to support lifestyle changes. These approaches aim to improve blood pressure control by integrating technology and personalized care, potentially making management more accessible and effective for patients.

What evidence suggests that this trial's treatments could be effective for managing high blood pressure following stroke?

This trial will compare Intensive Tailored Telehealth Management (ITTM) with Intensive Clinic Management (ICM) for controlling high blood pressure. Research has shown that ITTM, which participants in this trial may receive, can lower blood pressure in stroke patients by using technology for home monitoring and providing personalized advice. Early studies suggest that individuals who track their blood pressure and receive customized guidance can experience significant improvements.

In contrast, ICM, another treatment option in this trial, involves regular clinic visits to check and control blood pressure. This approach has proven effective in preventing strokes by maintaining healthy blood pressure levels. Research has shown that clinic visits, with close monitoring and regular check-ups, can effectively manage blood pressure. Both methods have shown promise in controlling high blood pressure.12678

Who Is on the Research Team?

Cheryl D. Bushnell, MD | Wake Forest ...

Cheryl Bushnell, MD

Principal Investigator

Wake Forest University Health Sciences

WR

Wayne Rosamond, MD

Principal Investigator

Wake Forest University Health Sciences

Are You a Good Fit for This Trial?

This trial is designed for individuals who have experienced a stroke and are now managing high blood pressure. Participants should be interested in using telehealth services or attending intensive clinic visits to manage their condition.

Inclusion Criteria

I have had a stroke confirmed by an MRI or CT scan.
Systolic Blood Pressure ≥ 130 mmHg
Able to read and understand English or Spanish
See 8 more

Exclusion Criteria

Transitioned to a facility such as skilled nursing or long-term care prior to enrollment
Mid upper arm circumference > 45 cm/17.7 inches or < 22 cm / 8.66 inches
Missing values for Systolic Blood Pressure or Privileged Access Management (PAM) score at baseline
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either Intensive Tailored Telehealth Management or Intensive Clinic Management for blood pressure control

6 months
Monthly visits (in-person or virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months
Bi-monthly visits (in-person or virtual)

Long-term follow-up

Participants are monitored for major adverse cardiovascular events and changes in cognitive function

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Intensive Clinic Management
  • Intensive Tailored Telehealth Management
Trial Overview The TEAMS-BP study compares two approaches: one where patients receive intensive management at clinics, and another where they get tailored support through telehealth technology to control their blood pressure after a stroke.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Intensive Tailored Telehealth Management (ITTM)Experimental Treatment1 Intervention
Group II: Intensive Clinic Management (ICM)Experimental Treatment1 Intervention

Intensive Clinic Management is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Intensive Clinic Management for:
🇪🇺
Approved in European Union as Intensive Clinic Management for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+

Published Research Related to This Trial

Intensive blood pressure control is both effective and cost-effective, but implementing it in everyday clinical practice faces significant challenges.
Team-based care models for managing hypertension have proven to be more effective than standard care, highlighting the need for further research on their cost-effectiveness and the barriers to their implementation.
Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care.Derington, CG., King, JB., Bryant, KB., et al.[2020]
Team-based care (TBC) that includes nonphysician members who can adjust blood pressure medications leads to a greater reduction in systolic blood pressure (-10.5 mm Hg) compared to TBC with only physician titration (-5.0 mm Hg) after 12 months, based on a meta-analysis of 19 studies with 5993 participants.
TBC with nonphysician titration is not only more effective in managing hypertension but also cost-effective, gaining more quality-adjusted life years (0.022) compared to TBC with physician titration, making it a valuable strategy for reducing hypertension-related health issues in the U.S.
Effectiveness and Cost-Effectiveness of Team-Based Care for Hypertension: A Meta-Analysis and Simulation Study.Bryant, KB., Rao, AS., Cohen, LP., et al.[2023]
In a study involving 103 patients in tele-ICU services, a total of 210 drug-related problems (DRPs) were identified, highlighting the importance of telepharmaceutical consultations in improving medication safety.
The implementation of telepharmaceutical consultations led to the discussion of significant drug-drug interactions and dosage adjustments, demonstrating that tele-ICU services can enhance the quality of care in remote areas lacking access to clinical pharmacists.
Medication safety in a German telemedicine centre: Implementation of a telepharmaceutical expert consultation in addition to existing tele-intensive care unit services.Amkreutz, J., Lenssen, R., Marx, G., et al.[2020]

Citations

Expert consensus on blood pressure management in critically ...This consensus proposes recommendations mainly focused on the implementation of blood pressure monitoring in critically ill patients, goal‑directed blood ...
Effectiveness evaluation of a hypertension management ...The objective of this study was to examine effectiveness of a Hypertension Management Program (HMP) in a Federally Qualified Health Center (FQHC).
The Management of Elevated Blood Pressure in the Acute ...This scientific statement aims to synthesize the available evidence, provide suggestions for best practice based on the available evidence, identify evidence- ...
Expert consensus on blood pressure management in ...This consensus proposes recommendations mainly focused on the implementation of blood pressure monitoring in critically ill patients.
Cost-effectiveness of Intensive Blood Pressure ManagementThis cost-effectiveness analysis evaluates the incremental cost-effectiveness of intensive blood pressure management compared with standard management in.
Value of Intensive Nursing Detail Management in ...Intensive nursing detail management is effective and safe in ICU nursing, so it is worthy of clinical application.
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...Clinical outcomes of intensive inpatient blood pressure management in hospitalized older adults. JAMA Intern Med. 2023;183:715–723. Crossref.
Intensive Systolic Blood Pressure Reduction and Kidney ...These findings suggest that intensive blood pressure control reduced the incidence of composite cardiovascular disease without increasing the risk of kidney ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security